NCT02660372View on ClinicalTrials.gov

Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia

PHASE3CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
Functional Dyspepsia
Interventions
DRUG

Imonogas

Simethicone 120 mg in gel capsules

DRUG

Espumisan

Simethicone 40 mg in gel capsules

Trial Locations (1)

117556

City Polyclinic #2 of Moscow Health Department, Moscow

All Listed Sponsors
lead

Johnson & Johnson Consumer and Personal Products Worldwide

INDUSTRY

NCT02660372 - Efficacy and Safety of Two Simeticone Brands in Adults With Functional Dyspepsia | Biotech Hunter | Biotech Hunter